RSS

Novartis

Novartis has announced its intention to acquire AveXis, Inc., a US-based Nasdaq-listed clinical stage gene therapy company, for USD 218 per share or a total of USD 8.7 billion in cash. Read more

GlaxoSmithKline plc (LSE/NYSE: GSK) has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion (£9.2 billion). Read more

IE SUBSCRIBE

Online Magazine

IE CZECH

IE Hungary

IE POLAND

IE Slovakia

IE AEROSPACE

IE AUTOMATION

IE AUTOMOTIVE

IE CHEMICALS

IE CONSTRUCTION

IE ENERGY

IE FOOD

IE HOME

IE METALS

IE Packaging

IE PHARMA